» Articles » PMID: 25163928

The Adaptor Protein P62 is Involved in RANKL-induced Autophagy and Osteoclastogenesis

Overview
Publisher Sage Publications
Specialty Biochemistry
Date 2014 Aug 29
PMID 25163928
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have implicated autophagy in osteoclast differentiation. The aim of this study was to investigate the potential role of p62, a characterized adaptor protein for autophagy, in RANKL-induced osteoclastogenesis. Real-time quantitative PCR and western blot analyses were used to evaluate the expression levels of autophagy-related markers during RANKL-induced osteoclastogenesis in mouse macrophage-like RAW264.7 cells. Meanwhile, the potential relationship between p62/LC3 localization and F-actin ring formation was tested using double-labeling immunofluorescence. Then, the expression of p62 in RAW264.7 cells was knocked down using small-interfering RNA (siRNA), followed by detecting its influence on RANKL-induced autophagy activation, osteoclast differentiation, and F-actin ring formation. The data showed that several key autophagy-related markers including p62 were significantly altered during RANKL-induced osteoclast differentiation. In addition, the expression and localization of p62 showed negative correlation with LC3 accumulation and F-actin ring formation, as demonstrated by western blot and immunofluorescence analyses, respectively. Importantly, the knockdown of p62 obviously attenuated RANKL-induced expression of autophagy- and osteoclastogenesis-related genes, formation of TRAP-positive multinuclear cells, accumulation of LC3, as well as formation of F-actin ring. Our study indicates that p62 may play essential roles in RANKL-induced autophagy and osteoclastogenesis, which may help to develop a novel therapeutic strategy against osteoclastogenesis-related diseases.

Citing Articles

Programmed Cell Death in Rheumatoid Arthritis.

Tong L, Qiu J, Xu Y, Lian S, Xu Y, Wu X J Inflamm Res. 2025; 18:2377-2393.

PMID: 39991656 PMC: 11846511. DOI: 10.2147/JIR.S499345.


GelMA@LNP/AST Promotes eNOS-Dependent Angiogenesis Through Autophagy Activation for the Treatment of Hind Limb Ischemia.

Lai L, Wu H, Peng L, Zhang Z, Wu X, Zheng S Int J Nanomedicine. 2025; 20:1821-1841.

PMID: 39958322 PMC: 11829644. DOI: 10.2147/IJN.S499478.


Cell-Type-Specific ROS-AKT/mTOR-Autophagy Interplay-Should It Be Addressed in Periimplantitis?.

Butucescu M, Imre M, Rus-Hrincu F, Voicu-Balasea B, Popa A, Moisa M Diagnostics (Basel). 2025; 14(24.

PMID: 39767145 PMC: 11727345. DOI: 10.3390/diagnostics14242784.


Lysosomal biogenesis and function in osteoclasts: a comprehensive review.

Jiang J, Ren R, Fang W, Miao J, Wen Z, Wang X Front Cell Dev Biol. 2024; 12:1431566.

PMID: 39170917 PMC: 11335558. DOI: 10.3389/fcell.2024.1431566.


Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues.

Chen W, Wang Q, Tao H, Lu L, Zhou J, Wang Q Acta Biochim Biophys Sin (Shanghai). 2024; 56(4):499-512.

PMID: 38439665 PMC: 11090848. DOI: 10.3724/abbs.2024017.


References
1.
von Metzler I, Krebbel H, Kuckelkorn U, Heider U, Jakob C, Kaiser M . Curcumin diminishes human osteoclastogenesis by inhibition of the signalosome-associated I kappaB kinase. J Cancer Res Clin Oncol. 2008; 135(2):173-9. DOI: 10.1007/s00432-008-0461-8. View

2.
Yip K, Feng H, Pavlos N, Zheng M, Xu J . p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone. Am J Pathol. 2006; 169(2):503-14. PMC: 1698794. DOI: 10.2353/ajpath.2006.050960. View

3.
Kim M, Ryu S, Choi J, Min Y, Kim S . Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts. J Cell Physiol. 2009; 221(3):618-28. DOI: 10.1002/jcp.21892. View

4.
Chung Y, Jang Y, Choi B, Song D, Lee E, Kim S . Beclin-1 is required for RANKL-induced osteoclast differentiation. J Cell Physiol. 2014; 229(12):1963-71. DOI: 10.1002/jcp.24646. View

5.
Xiu Y, Xu H, Zhao C, Li J, Morita Y, Yao Z . Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation. J Clin Invest. 2013; 124(1):297-310. PMC: 3871219. DOI: 10.1172/JCI66947. View